Back
Sep 29
Scientific
SS 16 - GU 4: Quality of Life Outcomes after Prostate Radiotherapy
MODERATOR(S)
Shalini Moningi, MD - Brigham and Womens/Dana Farber Cancer Institute
Mutlay Sayan, MD - Dana-Farber Cancer Institute
Credits
AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
10:45am - 12:00pm PT
GU 4: Quality of Life Outcomes after Prostate Radiotherapy
Speaker: Mutlay Sayan, MD - Dana-Farber Cancer Institute, Boston -
10:45am - 12:00pm PT
GU 4: Quality of Life Outcomes after Prostate Radiotherapy
Speaker: Shalini Moningi, MD - Brigham and Womens/Dana Farber Cancer Institute, Boston -
10:45am - 10:55am PT
Quality of life results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: James Yu, MD, FASTRO, MHS - Connecticut Radiation Oncology, PC, Hartford -
10:55am - 11:05am PT
-
11:05am - 11:15am PT
Long-Term Toxicity and Patient-Reported Quality of Life after Prostate IMRT with or without Biodegradable Balloon Rectal Spacer: Analysis of a Pivotal Randomized Trial
Speaker: Daniel Song, MD - Johns Hopkins University, Baltimore -
11:15am - 11:25am PT
-
11:25am - 11:35am PT
Hydrogel Spacer Quality Assurance (QA) in a Multi-Center Randomized Control Trial of Neurovascular-Sparing SAbR for Localized Prostate Cancer (PCa)
Speaker: Kareem Elfatairy, MD - University of Texas Southwestern Medical Center, Dallas -
11:35am - 11:45am PT
-
11:45am - 11:55am PT
Discussant
Speaker: William Jackson, MD - University of Michigan, Ann Arbor